The END Fund engaged in Mali after being asked by the Mali Ministry of Health, USAID, RTI International, and HKI to assist in the implementation of an emergency response NTD control program.
Mali had been successfully conducting NTD mass drug administration (MDA) campaigns since 2007 with funding from the US Agency for International Development (USAID) and support from implementing partner, Helen Keller International (HKI). Following the coup d'état in March 2012, USAID's funding for Mali was frozen, jeopardizing the country's MDA. The END Fund was able to respond quickly to the emergency call for help. A consortium of visionary investors ensured that millions of people were targeted with the medicines they needed.
On January 30, 2012, leaders from across the private sector, nonprofits, and governments gathered in London to announce their support for eliminating 10 neglected tropical diseases (NTDs) by 2020. A year later, the Global Network for Neglected Tropical Diseases spoke with many key leaders in the community to gain their perspectives on progress made and the challenges that remain.
In a new review on the social and economic impact of neglected tropical diseases (NTDs), Hudson Institute examines the seven most common NTDs, not only as health issues, but also as a global macroeconomic concern.
Significant progress has been made in recent years toward the control and elimination of neglected tropical diseases (NTD) in many parts of the world. RTI expert Eric Ottesen, MD talks about the next frontier in NTD control and accelerated efforts to overcome the global impact of these diseases. Dr. Ottesen is the program director of RTI's NTD Control Program (2006--2012) and ENVISION (2011--2016). He is also the director of the Task Force for Global Health's Lymphatic Filariasis Support Center.
Watch video from the landmark meeting held on January 30, 2012 where 13 pharmaceutical companies; the U.S., U.K., and U.A.E governments; the Bill & Melinda Gates Foundation; the World Bank; and other global health organizations announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 NTDs by the end of the decade. This pledge of renewed commitment, inspired by the WHO’s 2020 Roadmap on NTDs is being called the London Declaration.
The International Trachoma Initiative (ITI) and Pfizer go to Uganda to a school where children are receiving free antibiotic that treats and prevents blinding trachoma. ITI works with Pfizer Inc. and other international partners to eliminate blinding trachoma, an infectious eye disease that affects 41 million people, mostly women and children in remote areas that have limited access to water and sanitation. We have the tools to eliminate this disease by 2020. We need the political will to make it happen.